MedTrace Logo

Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee

NCT03850587 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 261

Last updated 2021-05-11

No results posted yet for this study

Summary

A Multi-center, Double-blinded, Randomized, Active-controlled, Parallel Design, phaseII Study to Investigate the Efficacy and Safety of YYC301 in Subject With Knee Osteoarthritis

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

Celecoxib 200mg

comparator medication

DRUG

Tramadol 37.5Mg+ Celecoxib 200mg

experimental medication

DRUG

Tramadol 75mg+ Celecoxib 200mg

experimental medication

DRUG

Tramadol 150mg+ Celecoxib 200mg

experimental medication

Sponsors & Collaborators

  • CliPS Co., Ltd

    collaborator INDUSTRY

  • Yooyoung Pharmaceutical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-30
Primary Completion
2020-05-12
Completion
2020-09-07

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03850587 on ClinicalTrials.gov